Bausch Health donates medication, products to COVID-19 fight
Bausch Health is donating medications and medical products, as well as increasing production of drugs that could be useful in treating COVID-19, according to a press release.
With thousands dying in Italy from the novel coronavirus, the Bausch Foundation has donated Virazole (ribavirin for inhalation solution, USP) for nebulization in compassionate use in Italian hospitals. In addition, Bausch + Lomb has donated Biotrue ONEday daily disposable contact lenses to health care providers in Wuhan, China, who have reported fogging eyeglasses while wearing protective gear, the release said.
In Spain, the company is donating Artelac Splash eye drops for use in hospitals. In addition, the company is increasing its manufacturing of chloroquine and azithromycin, with a plan to donate them when needed.
“Bausch Health is actively donating medicines and health care products to assist in the global fight against COVID-19 while also pursuing research to determine if products in our existing portfolio may offer valuable treatment options,” Joseph C. Papa, chairman and CEO, Bausch Health, said in the release. “In line with our mission of improving people’s lives with our health care products, we will continue to seek opportunities to offer support and aid to the institutions, patients and health care providers battling this pandemic.”